Latest News
SELLAS Life Sciences Surges 12% as Equity Value Soars $1.6B
SELLAS Life Sciences shares climbed 12.3% to $13.19, lifting estimated equity value by $1.62 billion since May. The REGAL trial's 80th event is pending.
BATL Stock Rises on Oil Rally, but $65.55 Hedges Limit Upside
Battalion Oil (BATL) climbed 10.2% on Friday alongside a 16% WTI rally, but fixed swaps at $65.55 per barrel cap further upside.
Grab Shares Slide 9% as Uber-Delivery Hero Deal Raises Incentive Concerns
Grab shares dropped 9.2% this week as Uber's $14.8 billion bid for Delivery Hero, covering foodpanda in five key markets, heightens scrutiny on incentive spending.
Celsius Shares Slide 3.3% as Loan Savings Highlight Margin Squeeze
Celsius (CELH) fell 3.3% to $28.99 after refinancing a $694.75M term loan, but interest savings are minor compared to margin erosion from acquisitions.
MARA Holdings Plunges 15% as CleanSpark Lease Highlights Revenue Gap
MARA Holdings stock dropped 15% in five sessions, far exceeding the Nasdaq's decline, as a CleanSpark lease deal highlights investor focus on signed revenue over potential capacity.
Pentagon Review Freezes $47B Onshore Wind Pipeline Amid State Opposition
A Pentagon review halt has frozen $47 billion in onshore wind projects, affecting 106 developments and nearly 30 GW of capacity across 21 states.
Lucid Stock Surges 59% in Three Days, But Cash Burn Concerns Loom
Lucid (LCID) shares surged 59% in three days, but Q2 deliveries annualized to 15,812 vehicles, nearly identical to 2025. Cash burn and liquidity remain key concerns.
Meta's 2026 Capex Forecast Exceeds Cash Flow, Shares Dip 2.7%
Meta shares fell 2.7% as its 2026 capex midpoint of $135 billion exceeded 2025 operating cash flow of $115.8 billion, highlighting a growing funding challenge.